CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,384,247
- in 9 filings, $4.7M under 10b5-1 plans
Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-06-10 | Herman Melanie J Interim CFO | Exercise or conversion | +1,500 | $11.91 | $18K | 4,486 |
| 2015-06-10 | Herman Melanie J Interim CFO | Exercise or conversion | +875 | $21.92 | $19K | 5,361 |
| 2015-06-10 | Herman Melanie J Interim CFO | Exercise or conversion | +1,750 | $68.48 | $120K | 7,111 |
| 2015-06-10 | Herman Melanie J Interim CFO | Sale | −4,125 | $93.50 | $386K | 2,986 |
| 2015-06-10 | Herman Melanie J Interim CFO | Exercise or conversion · Employee Stock Option (right to buy) | −1,500 | 875 | ||
| 2015-06-10 | Herman Melanie J Interim CFO | Exercise or conversion · Employee Stock Option (right to buy) | −875 | 1,312 | ||
| 2015-06-10 | Herman Melanie J Interim CFO | Exercise or conversion · Employee Stock Option (right to buy) | −1,750 | 4,250 | ||
| 2015-06-09 | HIGGINS JOHN L Chief Executive Officer | Sale | −6,200 | $92.53 | $574K | 129,844 |
| 2015-06-09 | HIGGINS JOHN L Chief Executive Officer | Sale | −3,300 | $93.21 | $308K | 126,544 |
| 2015-06-09 | HIGGINS JOHN L Chief Executive Officer | Sale | −500 | $95.06 | $48K | 126,044 |
| 2015-06-04 | Aryeh Jason Director | Sale | −1,640 | $92.68 | $152K | 244,836 |
| 2015-05-20 | Aryeh Jason Director | Sale | −1,000 | $87.65 | $88K | 246,476 |
| 2015-05-19 | Aryeh Jason Director | Sale | −2,240 | $88.82 | $199K | 247,476 |
| 2015-05-18 | Aryeh Jason Director | Sale | −6,000 | $86.74 | $520K | 249,716 |
| 2015-05-15 | KOZARICH JOHN W Director | Gift | −500 | 49,711 | ||
| 2015-05-14 | DeSilva Nishan M VP, Finance & Strategy and CFO | Exercise or conversion | +20,938 | $74.42 | $1.6M | 43,220 |
| 2015-05-14 | DeSilva Nishan M VP, Finance & Strategy and CFO | Sale | −20,938 | $83.84 | $1.8M | 22,282 |
| 2015-05-14 | DeSilva Nishan M VP, Finance & Strategy and CFO | Exercise or conversion · Employee Stock Option (right to buy) | −20,938 | 24,062 | ||
| 2015-05-13 | DeSilva Nishan M VP, Finance & Strategy and CFO | Exercise or conversion | +12,148 | $21.92 | $266K | 34,430 |
| 2015-05-13 | DeSilva Nishan M VP, Finance & Strategy and CFO | Sale | −12,148 | $83.23 | $1.0M | 22,282 |
Page 68 of 86 · 1,712 trades